M
Masaki Kato
Researcher at Kyushu University
Publications - 152
Citations - 5530
Masaki Kato is an academic researcher from Kyushu University. The author has contributed to research in topics: Internal medicine & Fatty liver. The author has an hindex of 34, co-authored 132 publications receiving 5017 citations. Previous affiliations of Masaki Kato include Osaka University & Kobe University.
Papers
More filters
Journal ArticleDOI
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
Masaki Kato,Millan S. Patel,Regis Levasseur,Ivan Borisovich Lobov,Benny Hung-Junn Chang,Donald A. Glass,Christine Hartmann,Lan Li,Tae-Ho Hwang,Cory Brayton,Richard A. Lang,Gerard Karsenty,Lawrence Chan +12 more
TL;DR: It is shown that mice with a targeted disruption of Lrp5 develop a low bone mass phenotype, and it is demonstrated that this phenotype becomes evident postnatally, and that it is secondary to decreased osteoblast proliferation and function in a Cbfa1-independent manner.
Journal ArticleDOI
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Motoyuki Kohjima,Munechika Enjoji,Nobito Higuchi,Masaki Kato,Kazuhiro Kotoh,Tsuyoshi Yoshimoto,Tatsuya Fujino,Masayoshi Yada,Ryoko Yada,Naohiko Harada,Ryoichi Takayanagi,Makoto Nakamuta +11 more
TL;DR: Examination of expression of fatty acid metabolism-related genes in NAFLD indicated increased de novo synthesis and uptake of fatty acids lead to further fatty acid accumulation in hepatocytes, and antioxidant pathways are activated to neutralize reactive oxygen species (ROS), which are overproduced during oxidative processes.
Journal ArticleDOI
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Motoyuki Kohjima,Nobito Higuchi,Masaki Kato,Kazuhiro Kotoh,Tsuyoshi Yoshimoto,Tatsuya Fujino,Masayoshi Yada,Ryoko Yada,Naohiko Harada,Munechika Enjoji,Ryoichi Takayanagi,Makoto Nakamuta +11 more
TL;DR: Analysis of the expression of genes regulating fatty acid synthesis by real-time PCR indicates that, in NAFLD, insulin signaling via IRS-1 causes the up-regulation of SREBP1-c, leading to the increased synthesis of fatty acids by the hepatocytes; negative feedback regulation via AMPK does not occur and the activation of Foxa2, following a decrease of IRS-2, up-regulates fatty acid oxidation.
Journal ArticleDOI
Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease
Nobito Higuchi,Masaki Kato,Yuki Shundo,Hirotaka Tajiri,Masatake Tanaka,Naoki Yamashita,Motoyuki Kohjima,Kazuhiro Kotoh,Makoto Nakamuta,Ryoichi Takayanagi,Munechika Enjoji +10 more
TL;DR: This work investigated the transcriptional factors and lipogenic genes activated in the liver with NAFLD and found that SREBP‐1c and ChREBP are transactivated by liver X receptor (LXR), a nuclear receptor that regulates the metabolism of cholesterol and fatty acids.
Journal Article
Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility.
Kenji Takaishi,Takuya Sasaki,Masaki Kato,Wataru Yamochi,Shinya Kuroda,T Nakamura,Masatoshi Takeichi,Yoshimi Takai +7 more
TL;DR: Results indicate that both rho p21 and rho GDI, but neither rac p21 nor ras p21, are involved in the HGF-induced cell motility.